MUSC Hollings Cancer Center

External Scientific Advisory Board

Formed in 2001, the External Scientific Advisory Board serves a key role in the Center's planning and evaluation of its research programs and supporting research inftrastructure. The ESAB is comprised of nationally-recognized leaders in cancer research and treatment, including current and former directors of cancer centers, national experts in areas of cancer research that match the HCC's research programs, and an experienced cancer center administrator.

 2016 Advisory Board Members

Lieping Chen, MD, PhD
Yale Cancer Center
Yale University

Edward Chu, MD
University of Pittsburgh Cancer Institute

Eric R. Fearon, MD, PhD
University of Michigan Comprehensive Cancer Center

I. David Goldman, MD
Albert Einstein Cancer
Yeshiva University

Yong-Jun Liu, MD, PhD
Baylor Research Institute
Baylor University Medical Center at Dallas

Elena Martinez, PhD
Moores Cancer Center
University of California, San Diego

Gina R. Petroni, PhD
UVA Cancer Center
University of Virginia

Edward A. Sausville, MD, PhD
Greenebaum Cancer Center
University of Maryland

David  F. Stern, PhD
Yale Cancer Center
Yale University

Douglas Yee, MD
Masonic Cancer Center
University of Minnesota


* This website is best viewed in Firefox or Chrome internet browsers.